XML 40 R25.htm IDEA: XBRL DOCUMENT

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

12 Months Ended

Dec. 31, 2018

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS



	Balance at Beginning of Period				Charged to Costs and Expenses				Other				Deductions				Balance at End of Period
Description	Balance at Beginning of Period				Charged to Costs and Expenses				Other				Deductions				Balance at End of Period
	(In thousands)
Year ended December 31, 2018
Allowance for doubtful accounts	$	8,882			$	557			$	(4,649	)	⁽³⁾	$	(1,071	)	⁽²⁾	$	3,719
Deferred tax assets valuation allowance	7,961				(894		)		—				(94		)		6,973
Year ended December 31, 2017
Allowance for doubtful accounts and sales returns and allowances	$	6,319			$	4,920			$	1,518		⁽¹⁾	$	(3,875	)	⁽²⁾	$	8,882
Deferred tax assets valuation allowance	3,604				740				3,617			⁽¹⁾	—				7,961
Year ended December 31, 2016:
Allowance for doubtful accounts and sales returns and allowances	$	5,572			$	2,009			$	—			$	(1,262	)	⁽²⁾	$	6,319
Deferred tax assets valuation allowance	4,887				(1,228		)		—				(55		)		3,604


⁽¹⁾	The above amounts primarily relate to amounts acquired through acquisition of Derma Sciences and effect of foreign currency translations.


⁽²⁾	Deductions primarily relates to allowance for doubtful accounts written off during the year, net of recoveries and other adjustments.


⁽³⁾	The Company transferred sales returns and allowances from accounts receivable, net to accrued expenses and other current liabilities upon adopting Topic 606 on January 1, 2018 using the modified retrospective method.